CAR-T

Legend

Fierce Pharma

J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T

The presentation was a comparison between anito-cel’s iMMagine-1 and Carvykti’s Cartitude-1 and -4 trials for the treatment of multiple myeloma.

Angus Liu Nov 12, 2025 11:36am

cancer target detection radiopharma radio

Lyell signs deal for phase 1-stage colorectal cancer CAR-T

Nov 10, 2025 9:45am

reshuffle pipeline target reorganize shift change

Sana, CAMP4 ditch clinical-stage assets for preclinical hopefuls

Nov 7, 2025 8:13am

Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background

Kyverna links CAR-T to autoimmune improvements in small trial

Oct 29, 2025 10:00am

Make a delay and accumulation of outstanding tasks Full stop

Regeneron does 180 on 2seventy lymphoma CAR-T

Oct 23, 2025 10:57am

kite

Kite puts $1.64B on the line for Pregene's in vivo CAR-Ts

Oct 16, 2025 4:56pm